Silk fibroin biomaterials for controlled release drug delivery

被引:247
作者
Pritchard, Eleanor M. [1 ]
Kaplan, David L. [1 ]
机构
[1] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA
关键词
biomaterials; controlled release; degradable polymer; reservoirs; silk fibroin; tissue engineering; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELL; IN-VITRO; ADENOSINE RELEASE; SCAFFOLDS; FILMS; POLYMER; RESPONSES; COATINGS; SYSTEMS;
D O I
10.1517/17425247.2011.568936
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Given the benefits of polymer drug delivery implants over traditional periodic systemic administration, the development of biomaterial systems with the necessary properties (biocompatibility, degradation, stabilization, controllability) is paramount. Silk fibroin represents a promising, naturally derived polymer for local, controlled, sustained drug release from fully degrading implants and the polymer can be processed into a broad array of material formats. Areas covered: This review provides an overview of silk biomaterials for drug delivery, especially those that can function as long-term depots. Fundamentals of structure and assembly, processing options, control points and specific examples of implantable silk drug delivery systems (sponges, films) and injectable systems (microspheres, hydrogels) from the 1990s and onwards are reviewed. Expert opinion: Owing to its unique material properties, stabilization effects and tight controllability, silk fibroin is a promising biomaterial for implantable and injectable drug delivery applications. Many promising control points have been identified, and characterization of the relationships between silk processing and/or material properties and the resulting drug loading and release kinetics will ultimately enhance the overall utility of this unique biomaterial. The ever-expanding biomaterial 'tool kit' that silk provides will eventually allow the simultaneous optimization of implant structure, material properties and drug release behavior that is needed to maximize the cost-efficiency, convenience, efficacy and safety of many new and existing therapeutics, especially those that cannot be delivered by means of traditional administration approaches.
引用
收藏
页码:797 / 811
页数:15
相关论文
共 115 条
[41]  
Kaplan, 1997, PROTEIN BASED MAT
[42]   Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells [J].
Karageorgiou, V ;
Meinel, L ;
Hofmann, S ;
Malhotra, A ;
Volloch, V ;
Kaplan, D .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 71A (03) :528-537
[43]  
Katayama H, 2000, BIOL PHARM BULL, V23, P1229, DOI 10.1248/bpb.23.1229
[44]   Spectroscopic investigation of tertiary fold of staphylococcal protein A to explore its engineering application [J].
Kikuchi, J ;
Mitsui, Y ;
Asakura, T ;
Hasuda, K ;
Araki, H ;
Owaku, K .
BIOMATERIALS, 1999, 20 (07) :647-654
[45]   Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin [J].
Kim, UJ ;
Park, J ;
Kim, HJ ;
Wada, M ;
Kaplan, DL .
BIOMATERIALS, 2005, 26 (15) :2775-2785
[46]   Structure and properties of silk hydrogels [J].
Kim, UJ ;
Park, JY ;
Li, CM ;
Jin, HJ ;
Valluzzi, R ;
Kaplan, DL .
BIOMACROMOLECULES, 2004, 5 (03) :786-792
[47]   The consolidation behavior of silk hydrogels [J].
Kluge, Jonathan A. ;
Rosiello, Nicholas C. ;
Leisk, Gary G. ;
Kaplan, David L. ;
Dorfmann, A. Luis .
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2010, 3 (03) :278-289
[48]   Silk fibroin nanoparticles for cellular uptake and control release [J].
Kundu, Joydip ;
Chung, Yong-Il ;
Kim, Young Ha ;
Taeb, Giyoong ;
Kundu, S. C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 388 (1-2) :242-250
[49]   Complex Coacervation-Controlled Release from Monoolein Cubic Phase Containing Silk Fibroin and Alginate [J].
Kwon, Taek Kwan ;
Kim, Jin-Chul .
BIOMACROMOLECULES, 2011, 12 (02) :466-471
[50]   Controlling silk fibroin particle features for drug delivery [J].
Lammel, Andreas S. ;
Hu, Xiao ;
Park, Sang-Hyug ;
Kaplan, David L. ;
Scheibel, Thomas R. .
BIOMATERIALS, 2010, 31 (16) :4583-4591